TY - JOUR
T1 - Fascicular and nonfascicular left ventricular tachycardias in the young
T2 - An international multicenter study
AU - Collins, Kathryn K.
AU - Schaffer, Michael S.
AU - Liberman, Leonardo
AU - Saarel, Elizabeth
AU - Knecht, Maria
AU - Tanel, Ronn E.
AU - Bradley, David
AU - Dubin, Anne M.
AU - Paul, Thomas
AU - Salerno, Jack
AU - Bar-Cohen, Yaniv
AU - Sreeram, Narayanswami
AU - Sanatani, Shubhayan
AU - Law, Ian H.
AU - Blaufox, Andrew
AU - Batra, Anjan
AU - Moltedo, Jose M.
AU - Van Hare, George F.
AU - Reed, John
AU - Ro, Pamela S.
AU - Kugler, John
AU - Anderson, Chris
AU - Triedman, John K.
PY - 2013/6
Y1 - 2013/6
N2 - Left Ventricular Tachycardia in Pediatrics Introduction The aim of this study was to evaluate the clinical presentation and outcomes of pediatric patients with ventricular tachycardia (VT) originating from left heart structures. Methods and Results This international multicenter retrospective study including 152 patients (age 10.0 ± 5.1 years, 62% male), divided into those with fascicular VT (85%, 129/152) and nonfascicular LV VT (15%, 23/152). All patients had a normal heart structure or only a minor cardiac abnormality. Adenosine was largely ineffective in both groups (tachycardia termination in 4/74 of fascicular VT and 0/5 of nonfascicular LV VT). In fascicular VT, calcium channel blockers were effective in 80% (74/92); however, when administered orally, there was a 21% (13/62) recurrence rate. In nonfascicular LV VT, a variety of antiarrhythmic therapies were used with no one predominating. Ablation procedures were successful in 71% (72/102) of fascicular VT and 67% (12/18) of nonfascicular LV VT on an intention to treat analysis. Major complications occurred in 5 patients with fascicular VT and 1 patient with nonfascicular LV VT. After a follow-up period of 2 years (1 day to 15 years), 72% of all patients with fascicular VT were off medications with no tachycardia recurrence. One patient died of noncardiac causes. In nonfascicular LV VT, follow-up was 3.5 years (0.5-15 years), P = 0.38. A total of 65% of these patients were free from arrhythmias. Two patients died suddenly (P < 0.01). Conclusion The clinical course and outcomes of pediatric patients with fascicular VT and nonfascicular LV VT are varied. Catheter ablation procedures can be curative.
AB - Left Ventricular Tachycardia in Pediatrics Introduction The aim of this study was to evaluate the clinical presentation and outcomes of pediatric patients with ventricular tachycardia (VT) originating from left heart structures. Methods and Results This international multicenter retrospective study including 152 patients (age 10.0 ± 5.1 years, 62% male), divided into those with fascicular VT (85%, 129/152) and nonfascicular LV VT (15%, 23/152). All patients had a normal heart structure or only a minor cardiac abnormality. Adenosine was largely ineffective in both groups (tachycardia termination in 4/74 of fascicular VT and 0/5 of nonfascicular LV VT). In fascicular VT, calcium channel blockers were effective in 80% (74/92); however, when administered orally, there was a 21% (13/62) recurrence rate. In nonfascicular LV VT, a variety of antiarrhythmic therapies were used with no one predominating. Ablation procedures were successful in 71% (72/102) of fascicular VT and 67% (12/18) of nonfascicular LV VT on an intention to treat analysis. Major complications occurred in 5 patients with fascicular VT and 1 patient with nonfascicular LV VT. After a follow-up period of 2 years (1 day to 15 years), 72% of all patients with fascicular VT were off medications with no tachycardia recurrence. One patient died of noncardiac causes. In nonfascicular LV VT, follow-up was 3.5 years (0.5-15 years), P = 0.38. A total of 65% of these patients were free from arrhythmias. Two patients died suddenly (P < 0.01). Conclusion The clinical course and outcomes of pediatric patients with fascicular VT and nonfascicular LV VT are varied. Catheter ablation procedures can be curative.
KW - cryoablation
KW - fascicular tachycardia
KW - idiopathic ventricular tachycardia
KW - pediatrics
KW - radiofrequency ablation
KW - ventricular tachycardia
KW - verapamil-sensitive VT
UR - http://www.scopus.com/inward/record.url?scp=84878595020&partnerID=8YFLogxK
U2 - 10.1111/jce.12105
DO - 10.1111/jce.12105
M3 - Article
C2 - 23437865
AN - SCOPUS:84878595020
SN - 1045-3873
VL - 24
SP - 640
EP - 648
JO - Journal of cardiovascular electrophysiology
JF - Journal of cardiovascular electrophysiology
IS - 6
ER -